Skip to main content

Table 2 Details of GxE interaction studies comprising at least 5,000 cases and 5,000 controls

From: Candidate gene-environment interactions in breast cancer

Reference

Study

SNPs

ERFs

Cases

Controls

Strongest interaction

Interaction effect size

UnadjustedP

Travis et al. [3]

Million women

12

10

7,610

10,196

CASP8-rs1045485; alcohol consumptiona

1.24

0.003

Milne et al. [4]

BCAC (1)

12

4

26,349

32,208

LSP1- rs3817198; parity

1.05

0.002

Campa et al. [6]

BPC3 (1)

17

9

8,576

11,892

5p12-rs10941679; use of estrogen only HRT

1.22

0.0072

Nickels et al. [5]

BCAC (2)

23

10

34,793

41,099

LSP1- rs3817198; parity

1.06

2.4 × 10-6

1p11.2-rs11249433; ever parous

1.16

5.3 × 10-5

CASP8-rs17468277; alcohol consumptiona

1.59

3.1 × 10-4

Barrdahl et al. [7]

BPC3 (2)

39

10

16,285

19,376

6q25-rs2046210; alcohol consumptiona

1.11

0.002

Schoeps et al. [12]

BCAC

71,527

10

34,475

34,786

21q22.12-rs10483028 and rs2242714; postmenopausal BMI

0.84

3.2 × 10-5

  1. aAlcohol consumption was defined as per additional 10 g in Travis et al. and Barrdahl et al. and as < or ≥20 g/per day by Nickels et al. BCAC, Breast Cancer Association Consortium; BMI, body mass index; BPC3, Breast and Prostate Cancer Cohort Consortium; ERFs, established risk factors for breast cancer; HRT, hormone replacement therapy.